All Type of News
Administrative litigation against Ezmedicom's drug fee eyed
Domestic wholesaling industry will lodge an administrative litigation against Ezmedicom's arbitrary drug fee imposition of 0.9 percent as its stern countermeasure, while presenting to Chong Wa Dae (Presidential House)...
Pfizer Korea decides to lower insurance price of Norvasc by 1 won
Pfizer Korea said the government should cut down the reimbursement price of Norvasc (amlopidpine), a long-acting calcium channel blocker, by 1 won from this April.
The company said, "The government has informed us...
TB mortality in Korea ranked the top over OECD nations.
The TB patient report survey in 2002 revealed that its mortality of Korea was the top rank over the OECD nations, raising an absolute necessity for the TB control.
The MOHW, the Korea TB Association and the Intern...
Fresh pharmacists hardly get pharmacy jobs.
About 1,250 new pharmacists came in this year as well but hardly get the pharmacy jobs that used to provide higher salaries than any other works, largely because the pharmacy avoided to give job opportunities for them...
Blue House to scrap Special Councils for Medical and Pharmaceutical Development
The Special Council for Medical and Pharmaceutical Development has advised to the President as an affiliate advise group for the medical and pharmaceutical system improvement and development during the past one year o...
KFDA to expedite rapid industrialization plan for potential biological preparations
The Korea Food and Drug Administration announced it would finalize a rule concerning the license and screening of biological preparations via a series of relevant meetings with specialists from related organizations ...
Ezmedicom clarifies several controversial issues
Stimulated by the recent e-commerce tender results that of the 11 drug wholesaler registered, more than 50 percent were successful bidders in Seoul National University Hospital, Ezmedicom are endeavoring to advocate i...
Olanzapine should be contraindicated in patients with diabetes
The Korea Food and Drug Administration has recently published a safety bulletin, including side effects and interactions of drugs based on various information sources from domestic pharmaceutical firms, World Health O...
Chosun Pharm concentrates its efforts on streamlining its organizations as herbal maker
Chosun Pharm cerebrated its 78-year foundation day on March 14, renewing its determination as re-born herbal maker.
In his congratulatory speech, Park Chong-whan, a committee chief for management normalization sai...
Zuellig Pharma Korea grapples with tougher domestic market
Following revelation of Zuellig Pharma Korea's two-year consecutive deficits, there are lingering concerns about its successful presence (or viability) in the domestic market, as its financial index have successfully ...
